
NANOPATH INC.
Diagnostics for Women
WEST LEBANON, United States · Founded 2022 · $10.0M raised
- Headquarters
- WEST LEBANON, New Hampshire
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- nanopath.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series AAug 2022
- Rounds
- 1
About
Nanopath is a women's health diagnostics company developing a first-in-class point-of-care molecular diagnostic platform using nanobiosensing technology. Their platform detects viral, bacterial, and fungal pathogens without nucleic acid amplification, delivering results in under 20 minutes directly in a clinician's office. Founded by Dr. Amogha Tadimety and Dr. Alison Burklund, the company raised $10M in Series A funding co-led by Norwest Venture Partners.
Summary
NANOPATH INC. is a Biotech company based in WEST LEBANON, United States, founded in 2022. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Aug 2022. Investors include Shiv Chaudhary, Medtech Convergence Fund and Alumni Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2022
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company
